Skip to content

DexCom

US · DXCM #635 by market cap Listed 2005
79.32 -0.87 -1.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 80.27 +0.10%
After-hours 78.18 -1.44%
Overnight 80.75 +0.70%
92.3467.3579.322026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on DXCM?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +11.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 4.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 31.2x Better than 21%
Forward P/E 27.3x Better than 21%
Price / Sales 5.8x Better than 19%
P/E vs own 5-yr range 6th pctl Better than 94%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 17.0% Better than 78%
Net income CAGR (3Y) 34.8% Better than 83%
Free cash flow CAGR (3Y) 52.3% Better than 85%
Profitability A

How much profit the business keeps from each dollar of sales and capital.

Gross margin 60.1% Better than 74%
Operating margin 19.6% Better than 75%
Net margin 17.9% Better than 76%
Return on equity 34.5% Better than 90%
Return on invested capital 17.3% Better than 86%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -14.1% Better than 41%
6-month return 10.0% Better than 72%
12-month return (ex latest month) 30.0% Better than 69%
Distance below 52-week high 14.3% Better than 73%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.9x Better than 53%
Debt to assets 21.9% Better than 53%
Interest coverage 60.5x Better than 91%
Free cash flow / net income 128.8% Better than 57%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 93.3% Better than 76%
Upside to average target 25.1% Better than 41%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -4.81%
1M -7.49%
3M -12.08%
6M +11.03%
YTD +19.51%
1Y +35.78%
3Y -27.20%
5Y -50.52%

Key statistics

Price & volume

Prev close
80.19
Open
80.48
Day range
78.75 - 81.58
Avg price
79.69
Volume
4.61M
Turnover
367.25M
Amplitude
3.53%
52-week range
56.72 - 92.59

Valuation

P/E
37.95
P/E (TTM)
31.23
P/B
11.67
EPS
2.09
Net profit
779.47M
Net assets
2.54B

Share structure

Market cap
29.58B
Float cap
29.48B
Shares out
372.95M
Float shares
371.61M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2005-04-14
52-week range 63% of range
56.72 92.59

14.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-57.18M net over the window

Short interest

Shares short
15.93M
As of
2026-10-30

Frequently asked questions

What is the current stock price of DexCom (DXCM)?

DexCom last traded at 79.32. This page shows a periodic quote snapshot. Check the displayed quote time.

What is DexCom's market cap?

About 29.58B.

What is the P/E ratio of DexCom?

The trailing twelve-month P/E is 31.23, below its own 5-year average of 106.28 — toward the bottom of its historical range (5.66% percentile). See the Valuation tab for the full history.

Does DexCom pay a dividend?

DexCom does not currently pay a regular dividend.

Is DexCom a buy according to analysts?

The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 99.21, which implies 25.1% upside from the current price. This is not investment advice.

What is DexCom's StockVane Quant Rating?

The StockVane Momentum strategy currently rates DexCom a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.

DexCom discussion 0 comments

Add a comment